Why Does Your Mounjaro Pen Have 5 Doses Inside It?

Every Mounjaro KwikPen holds five doses of liquid, but the licensed schedule delivers four weekly injections per pen — one month of treatment.
The extra (fifth) dose is manufacturing overfill, present to ensure each of your four injections contains the precise amount of tirzepatide stated on the label.
Attempting to extract a fifth injection is not recommended and may result in an inaccurate, incomplete dose.
The pen is pre-set to the correct dose for your prescription; you do not adjust it yourself, any change to dose or timing is a clinical decision made by your prescriber.

Each Mounjaro KwikPen contains five doses, but you only inject four of them. The fifth is intentional: it's built-in overfill that ensures all four of your prescribed weekly doses are actually delivered in full, even accounting for the small amount of liquid that stays in the needle or is lost during the injection process. That five-dose count isn't a mistake or a bonus — it's how the pen is engineered to guarantee accuracy across a full four-week supply. Mounjaro is a prescription-only medicine, so the pen you receive has been assessed and authorised for you specifically by a GPhC-registered prescriber before it leaves the pharmacy.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The engineering behind Mounjaro's five-dose design, and what it means in practice

So why exactly does the pen hold an amount equivalent to five doses if only four are prescribed?

Pharmaceutical pens are filled with a small quantity of liquid beyond the labelled dose count. This is standard across injectable medicines and is sometimes called overfill or overrun. Its purpose is precise: during manufacture, filling and sterilisation, tiny volumes are consumed. When you prime the pen before your first injection, a small amount is expelled. Each time you click the button, a fraction stays in the needle hub rather than reaching the tissue beneath your skin.

Without that built-in surplus, the fourth and final dose in a pen might fall fractionally short of the correct amount of tirzepatide. Eli Lilly engineers the KwikPen so that all four scheduled injections deliver the full stated dose, whether that is 2.5 mg, 5 mg or any strength up to 15 mg. The NHS patient information page for tirzepatide confirms the standard dosing unit as a four-week supply per pen. So the short answer to whether the Mounjaro pen has five doses in the clinical sense: no. It holds the equivalent volume of five, and you use four.

You can read more about exactly how many doses are in a Mounjaro pen and how each one is counted, including what to do if the pen feels empty before the fourth injection.

Is trying to use that fifth dose safe, or does it just waste medication?

It is a question our prescribers hear fairly often, and the straightforward answer is: do not attempt it. The KwikPen is not designed to dispense a fifth injection. Once the four prescribed doses have been given, the mechanism is exhausted and any remaining liquid cannot be reliably accessed or dosed.

Even if a small amount of solution is visible in the cartridge window after the fourth dose, there is no way to confirm the volume or concentration of what remains. Attempting an improvised injection risks an underdose, an air injection, or damage to the pen mechanism. The only safe course is to dispose of the used pen in a sharps container and begin a new pen for the next weekly dose.

Understanding why Mounjaro has an extra dose built in removes the temptation to chase that fifth shot. The overfill is there to protect the accuracy of doses one through four, not to provide a bonus injection. Treating it as one would misuse the pen's design and, more importantly, undermine the clinical precision your prescriber has factored into your treatment plan.

Does the five-dose design affect how you store or handle the pen between injections?

Not directly, but it is worth understanding the pen's mechanics so you handle it correctly across all four doses. Keep the pen capped between injections, the overfill is liquid medication that can degrade if exposed to light or temperature extremes. Many people find it easiest to store the pen in the fridge door, where it stays visible and accessible without being buried behind other items, but removed enough from the freezer compartment to avoid accidental freezing.

Storage must follow the Mounjaro Summary of Product Characteristics precisely: refrigerated at 2–8°C before first use, with a limited period of room-temperature storage permitted after the pen has been opened, the exact duration is stated in your patient information leaflet and should be your reference, not third-party advice. You can check Mounjaro 5mg and other strength-specific pages for guidance relevant to your current dose.

Between injections, use a fresh needle each time. Reusing needles increases the risk of blocked tips, inaccurate dosing and injection-site discomfort. Rotate the injection site (abdomen, thigh and upper arm are all licensed locations) and note any redness or swelling at the site. Side-effect questions and any concerns about how the pen is performing should go to your prescriber or pharmacist, not to online forums. The full Mounjaro overview covers storage, injection technique and what to expect across the titration schedule.

Does knowing the pen holds five doses change anything about your dose schedule or titration?

No. The five-dose volume is an engineering feature, not a clinical one. Your prescribed schedule (when to inject, at what strength, and when or whether to increase) is determined entirely by your prescriber based on your response to treatment and how well you are tolerating it. The pen count does not create an extra injection week, and it does not signal that your dose is due sooner or later than planned.

If you are wondering whether you need to move to a higher strength, that is a separate question covered well by why Mounjaro doses are increased over time and by whether a dose increase is actually compulsory. The short version: titration is clinically guided, not automatic. Some people stay at a particular dose for longer than the minimum four-week interval; others progress sooner. What matters is that the decision is made with clinical input, not based on how many doses appear to be left in the pen.

For broader context on where Mounjaro sits in private weight management, the Mounjaro cost and pricing guide sets out what an honest private prescription includes. And if you are still building a picture of what results to expect at the early stage of treatment, average weight loss at 2.5 mg gives a grounded, evidence-based starting point drawn from the SURMOUNT clinical programme, published in the New England Journal of Medicine.

If you have not yet started treatment and want to understand whether Mounjaro is clinically appropriate for you, the team at nume reviews every consultation personally, a named prescriber reads your answers, not a decision tree. Check your eligibility and, if suitable, your prescription and pen can be with you the next working day.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions